SPONSOR
Novo Nordisk A/S
Total Trials
11
Recruiting
11
Phases
Phase 1, Phase 3, Phase 4, Phase 2
Conditions studied: ObesityHealthy VolunteersHeart FailureDiabetes Mellitus, Type 2OverweightObstructive Sleep ApnoeaSevere Postpartum HaemorrhageLiver DiseaseChronic Kidney DiseaseType 2 Diabetes
Novo Nordisk A/S is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Obesity, Healthy Volunteers, Heart Failure, Diabetes Mellitus, Type 2.
The trial portfolio spans Phase 1, Phase 3, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Novo Nordisk A/S
How many clinical trials has Novo Nordisk A/S sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by Novo Nordisk A/S, of which 11 are actively recruiting participants. These trials cover conditions including Obesity, Healthy Volunteers, Heart Failure. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Novo Nordisk A/S research focus on?
Novo Nordisk A/S clinical trials span Obesity, Healthy Volunteers, Heart Failure, Diabetes Mellitus, Type 2, Overweight, and additional conditions. The research pipeline includes Phase 1, Phase 3, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Novo Nordisk A/S clinical trial?
To participate in a Novo Nordisk A/S trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Novo Nordisk A/S trials with current recruitment status updated daily.
Clinical Trials by Novo Nordisk A/S
NCT07153172 Phase 1
Recruiting
Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108
Obesity
NCT07656454 Phase 1
Recruiting
A Study Understanding How Much CDR132L Enters the Bloodstream After Injection Under the Skin Compared to Injection Into a Vein in Healthy Participants
Healthy Volunteers
NCT07817251 Phase 3
Recruiting
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
Diabetes Mellitus, Type 2
NCT07571109 Phase 3
Recruiting
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Obesity
NCT07532863
Recruiting
A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants
Diabetes Mellitus, Type 2
NCT07339423 Phase 3
Recruiting
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Obesity
NCT07157423 Phase 4
Recruiting
A Research Study to See How Safe is Eptacog Alfa When Used to Stop Heavy Bleeding in Women After Giving Birth in India
Severe Postpartum Haemorrhage
NCT07682363
Recruiting
Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Among Chinese Physicians
Liver Disease
NCT06717698 Phase 2
Recruiting
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
NCT07557953 Phase 1
Recruiting
A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity
Overweight
NCT07868354 Phase 1
Recruiting
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication
Overweight
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology